Medicare Enrolled
Dr. Pratik Desai, MD
Cardiovascular Disease · Cary, NC
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Desai from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Desai?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Desai
Dr. Pratik Desai is a cardiovascular disease specialist in Cary, NC, with 20 years of NPI registration. Based on federal Medicare data, Dr. Desai performed 5,842 Medicare services across 2,716 unique beneficiaries.
Between the years covered by Open Payments, Dr. Desai received a total of $12,175 from 43 pharmaceutical and/or device companies across 702 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Desai is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 6% volume in NC
$12,175 industry payments
Medicare Practice Summary
Medicare Utilization ↗5,842
Medicare services
Top 6% in NC for cardiovascular disease
2,716
Unique beneficiaries
$62
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~292 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
976 | $88 | $298 |
| Remote vital sign monitoring management, each additional 20 minutes This code covers the time spent by a provider managing patient data from remote vital sign monitoring devices. It applies to each additional 20-minute increment beyond the initial monthly service period. |
711 | $29 | $119 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
658 | $35 | $176 |
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
640 | $35 | $146 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
391 | $10 | $54 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
260 | $43 | $161 |
| Technetium Tc-99m sestamibi diagnostic injection A diagnostic injection of technetium Tc-99m sestamibi used for imaging studies. |
192 | $88 | $188 |
| Remote pacemaker/defibrillator monitoring, 90 days Remote evaluation of a pacemaker or implantable defibrillator system within 90 days of the last check. |
181 | $15 | $82 |
| Tc-99m radiopharmaceutical, non-highly enriched uranium source This code covers the cost of Technetium-99m radiopharmaceuticals derived from non-highly enriched uranium sources. It is billed as an add-on per study dose for full cost recovery. |
163 | $8 | $10 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
157 | $138 | $601 |
| Remote pacemaker monitoring, 90 days Remote assessment of a pacemaker system, including single, dual, multiple lead, or leadless devices, performed up to 90 days apart. |
151 | $21 | $96 |
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
116 | $6 | $36 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
113 | $58 | $202 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
108 | $93 | $290 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
96 | $328 | $1,410 |
| Ultrasound of arm or leg veins An ultrasound exam of the veins in the arm or leg. The test uses sound waves to check blood flow and may include compression and other maneuvers. |
79 | $129 | $520 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
52 | $111 | $459 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
51 | $48 | $251 |
| Principal care management for high-risk disease, first 30 minutes This service involves 30 minutes of personal care management by a qualified healthcare professional for a patient with a single high-risk disease, billed per calendar month. |
50 | $63 | $242 |
| Ultrasound of arm or leg veins An ultrasound exam of the veins in one arm or leg using compression and other maneuvers to assess blood flow and check for blockages. |
49 | $81 | $332 |
| Remote cardiac rhythm monitor evaluation, up to 30 days Review and analysis of data from a remote cardiac rhythm monitoring system over a period of up to 30 days. |
46 | $17 | $81 |
| Remote monitoring of implantable heart rhythm device Evaluation of data transmitted remotely from an implantable cardiovascular monitor, such as a loop recorder or subcutaneous cardiac rhythm monitor, over a period up to 30 days. |
46 | $42 | $84 |
| Echocardiogram, transthoracic An ultrasound test that uses sound waves to create images of the heart's blood flow, valves, and chambers. |
42 | $39 | $153 |
| Echocardiogram with color Doppler An ultrasound of the heart that uses color imaging to visualize blood flow, measure flow rate, and assess valve function. |
42 | $18 | $161 |
| Stress echocardiogram with ECG monitoring An ultrasound of the heart performed while monitoring heart rhythm during rest, exercise, or medication-induced stress, followed by a review and report of the findings. |
42 | $165 | $686 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
41 | $101 | $384 |
| 30-day continuous ECG with patient-triggered event transmission and review This procedure involves continuous electrocardiogram monitoring for up to 30 days, including the transmission of patient-triggered events. A healthcare professional reviews the data and provides a report. |
39 | $617 | $2,075 |
| Continuous ECG monitoring, up to 30 days Continuous heart rhythm monitoring for up to 30 days, including professional review and reporting of the results. |
38 | $20 | $74 |
| Pacemaker programming, dual lead system Adjustment and configuration of a dual-lead pacemaker device to ensure proper operation and settings. |
36 | $57 | $170 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
36 | $62 | $203 |
| External EKG monitoring, 8-15 days Continuous external electrocardiogram recording and review over a period of 8 to 15 days to monitor heart rhythm. |
34 | $18 | $74 |
| Continuous external EKG monitoring, 8-15 days This procedure involves recording heart rhythm continuously using an external EKG device over a period of 8 to 15 days. |
33 | $8 | $40 |
| Remote evaluation of implantable defibrillator system Remote assessment of a single, dual, or multiple lead implantable defibrillator system within 90 days of the previous evaluation. |
31 | $23 | $189 |
| Ultrasound of leg arteries or grafts An imaging test that uses sound waves to create pictures of the blood vessels in the legs or any surgical grafts present. |
31 | $177 | $505 |
| Additional 30 minutes of principal care management This service covers an additional 30 minutes of care management for a single high-risk disease, provided personally by a qualified healthcare professional each calendar month. |
26 | $45 | $174 |
| Cardiac catheterization | 23 | $179 | $885 |
| Sedation by physician, initial 15 minutes Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older. |
22 | $10 | $37 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
14 | $131 | $509 |
| Chemical destruction of first incompetent vein with imaging guidance This procedure uses imaging guidance to chemically destroy the first incompetent vein in the arm or leg. |
13 | $1,273 | $6,047 |
| Ultrasound of arm and leg arteries A non-invasive imaging test that uses sound waves to examine the blood vessels in the arms and legs. It evaluates blood flow and checks for blockages or other vascular issues. |
13 | $97 | $451 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
10.6% high complexity
15.1% medium
74.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$12,175
Total received (2018-2024)
Avg $1,739/year across 7 years
Top 22% in NC for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
43
Companies
702
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,157 (99.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$18 (0.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,507
2023
$1,201
2022
$1,478
2021
$1,866
2020
$1,624
2019
$2,089
2018
$2,411
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
E.R. Squibb & Sons, L.L.C.
$342
Esperion Therapeutics, Inc.
$189
Novartis Pharmaceuticals Corporation
$173
Novo Nordisk Inc
$137
Boehringer Ingelheim Pharmaceuticals, Inc.
$105
Baxter Healthcare
$90
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$88
Amgen Inc.
$74
AstraZeneca Pharmaceuticals LP
$63
ABIOMED
$42
Kestra Medical Technology Services, Inc.
$41
HEARTFLOW, INC.
$40
Medtronic, Inc.
$22
Kiniksa Pharmaceuticals International, plc
$21
Becton, Dickinson and Company
$17
SANOFI-AVENTIS U.S. LLC
$16
Janssen Pharmaceuticals, Inc
$16
Edwards Lifesciences Corporation
$14
GENZYME CORPORATION
$13
Top 3 companies account for 46.8% of 2024 payments
All-time payments by company (2018-2024) ›
E.R. Squibb & Sons, L.L.C.
$1,457
Amgen Inc.
$1,319
AngioDynamics, Inc.
$1,267
AstraZeneca Pharmaceuticals LP
$1,131
Novartis Pharmaceuticals Corporation
$1,102
Janssen Pharmaceuticals, Inc
$975
Boehringer Ingelheim Pharmaceuticals, Inc.
$711
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$675
Esperion Therapeutics, Inc.
$524
SANOFI-AVENTIS U.S. LLC
$346
Novo Nordisk Inc
$320
Amarin Pharma Inc.
$246
Cardiovascular Systems Inc.
$246
Baxter Healthcare
$222
PFIZER INC.
$167
Celgene Corporation
$118
Abbott Laboratories
$110
Actelion Pharmaceuticals US, Inc.
$104
AbbVie Inc.
$100
Medtronic Vascular, Inc.
$90
Edwards Lifesciences Corporation
$89
GENZYME CORPORATION
$89
Cook Medical LLC
$88
Lilly USA, LLC
$76
Medtronic, Inc.
$74
Lundbeck LLC
$73
ABIOMED
$73
Kestra Medical Technology Services, Inc.
$41
HEARTFLOW, INC.
$40
Merck Sharp & Dohme Corporation
$36
Braemar Manufacturing, LLC
$35
ARBOR PHARMACEUTICALS, INC.
$29
Regeneron Healthcare Solutions, Inc.
$26
Janssen Scientific Affairs, LLC
$24
Kiniksa Pharmaceuticals, Ltd.
$22
Kiniksa Pharmaceuticals International, plc
$21
Chiesi USA, Inc.
$20
Merck Sharp & Dohme LLC
$19
Becton, Dickinson and Company
$17
United Therapeutics Corporation
$14
Philips Electronics North America Corporation
$14
Biocompatibles, Inc.
$11
iRhythm Technologies, Inc.
$11
Top 3 companies account for 33.2% of all-time payments
Associated products mentioned in payments ›
(5044) MCOT · Arcalyst · Assure WCD · BRILINTA · Bidil · CAMZYOS · CARDIOMEMS · COREVALVE EVOLUT R · Cardiac Monitoring Suite · CardioMEMS HF System · Corlanor · Coronary Orbital Atherectomy System · Diamondback Peripheral · ELIQUIS · ENTRESTO · Edwards SAPIEN 3 Transcatheter Heart Valve · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · FABRAZYME · FARXIGA · FFRct · Hillrom - Cardiac Ambulatory Monitor · Impella · JARDIANCE · KENGREAL · LEQVIO · LOKELMA · LifeVest · MULTAQ · Mitra Clip system · NEXLETOL · NEXLIZET · NORTHERA · OPSUMIT · OPSUMIT MACITENTAN · ORENITRAM · Ozempic · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Peripheral Orbital Atherectomy System · RYBELSUS · Repatha · Reveal LINQ · Rybelsus · SUTENT · Saxenda · Tornado · UBRELVY · UPTRAVI · VARITHENA · VERQUVO · VYNDAQEL · Vascepa · VenaSeal · Venclose Maven Catheter · Wegovy · XARELTO · ZIO Patch
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Cardiologists within 10 mi
121
Per 100K population
10.5
County median income
$101,763
Nearest hospital
WAKEMED, CARY HOSPITAL
2.4 mi
2.4 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Desai is a clinical cardiology specialist, with above-average Medicare volume (top 6% in NC), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Desai experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Desai performed 976 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Desai receive payments from pharmaceutical companies?
Yes. Dr. Desai received a total of $12,175 from 43 companies across 702 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Desai's costs compare to other cardiologists in Cary?
Dr. Desai's average Medicare payment per service is $62. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Desai) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Cary
Browse cardiologists in Cary ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in NC
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in NC
Which NC cardiologists receive the most from drug and device companies.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
AngioDynamics, Inc. Payments to Doctors
See all physicians who received payments from AngioDynamics, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology